This study focuses on Alzheimer’s disease, a condition that affects memory and cognitive function. The research aims to understand how brain cell changes relate to the progression of the disease. The study will use several specialized imaging substances including [18F]RO6958948, 11C-UCB-J, 18F-DPA-714, and [11C]PiB, which are administered through injection into a vein to create detailed images of the brain.
During the study, participants will receive these imaging substances at different times to examine various aspects of brain activity. The substances will help researchers see specific changes in brain cells, particularly focusing on how certain brain cells called microglia become activated and how this affects the connections between brain cells called synapses. Each imaging session involves receiving a small amount of the imaging substance through an intravenous injection.
The imaging will be performed using a special scanning technique called Position Emission Tomography (PET), which creates detailed pictures of the brain. This allows researchers to observe and measure changes in the brain that are characteristic of Alzheimer’s disease. The study will track these changes over time to better understand how the disease progresses and affects different parts of the brain.



France